Search

Boehringer Ingelheim opens Health Management Centre in China

Boehringer Ingelheim opens Health Management Centre in China The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools The centre further strengthens the company’s ability to provide services along the f

Mareks Disease Poultry Chicken

Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems.

European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares

European Commission grants marketing authorization for spesolimab, the first specific treatment option for generalized pustular psoriasis flares in adults

InSensitive Content: the impact on dermatologists

Learn about the importance of the dermatology community sharing content related to generalized pustular psoriasis on social media.

CHMP recommends new treatment for chronic kidney disease

The CHMP of EMA has granted a positive opinion recommending empagliflozin for the treatment of adults with chronic kidney disease

Promising phase II results in chronic kidney disease

Boehringer Ingelheim’s investigation of novel compound on top of standard of care empagliflozin shows promising results for chronic kidney disease

U.S. FDA approves first treatment for generalized pustular psoriasis flares in adults

Boehringer Ingelheim announces the U.S. FDA has approved the first treatment for generalized pustular psoriasis (GPP) flares in adults

Generalized pustular psoriasis at EADV 2021

Dr. Emmanuelle Clerisme-Beaty (former Associate Head of Medicine - Inflammation, Boehringer Ingelheim) reflects on developments for GPP at the EADV congress, 2021

Implementing the generalized pustular psoriasis (GPP) Charter

Read more about the projects are implementing the generalized pustular psoriasis (GPP) Charter

Genomic Lens Linking Worlds in DNA

Adding a new dimension to drug discovery with the help of data science and DNA

Over 100 billion birds vaccinated with VAXXITEK

Boehringer Ingelheim celebrates that over 100 billion birds have been vaccinated with VAXXITEK® HVT + IBD in October 2018.

BI increases commitments to sustainable development

At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development

Advances in vectored vaccines for poultry

Vaccine design technologies have made huge advances in recent years. One of the newer categories of vaccine, vectored vaccines, is overcoming challenges that conventional vaccines do not meet.

Sarcoma

Hear from Gary Schwartz, MD, Director of the Case Comprehensive Cancer Center, Cleveland, Ohio, talk about his expert perspectives on sarcoma.

The GPP Forum

The generalized pustular psoriasis (GPP) Forum - a multistakeholder event collaborating for a new vision for people living with GPP

New spesolimab data show significant improvement in GPP flares

Chronic Kidney Disease

Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.

Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim

Explore the potential of big molecules with BioXcellence, offering advanced biopharmaceutical production services to unlock new possibilities in healthcare.

Disentangling fibrosis

Fibrosis is an important area of research for Boehringer Ingelheim that is focusing on fibrotic conditions of the liver, lung, kidney, skin and gut.

new_analysis_nintedanib_SSc_ILD

Interim analysis results support long term treatment with nintedanib in SSc-ILD patients

IPF why wait?

IPF is a progressive and life threatening lung disease that can cause permanent damage in the lungs right from the start. Early diagnosis and treatment of IPF is critical, because acting quickly can make a difference.

It’s Your Heart. Protect It. The Podcast.

In season 2, we hear from a range of experts to explore further how the interconnected systems call for collaboration and approach to care.

Shared science for the best cat diabetes management

Diabetes mellitus is a common endocrine disease with increasing prevalence in dogs and cats. Learn how science's made management easier.

Research Beyond Borders Partnering

Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.

InSensitive Content: impact on the GPP patient community

Understand why the patient community should be able to post and consume visual content related to generalized pustular psoriasis.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers